Roberto Bizzotto

Shift to Fatty Substrate Utilization in Response to Sodium–Glucose Cotransporter 2 Inhibition in Subjects Without Diabetes and Patients With Type 2 Diabetes

Ele Ferrannini, Simona Baldi, Silvia Frascerra et al. · Diabetes · 2016 · 714 citations

Life Sciences, Endocrinology, Pharmacology +12

A reference map of potential determinants for the human serum metabolome

Noam Bar, Tal Korem, Omer Weissbrod et al. · Nature · 2020 · 449 citations · Full text

Life Sciences, Biochemistry, Mass Spectrometric Analysis +15

Pharmacogenomics of GLP-1 receptor agonists: a genome-wide analysis of observational data and large randomised controlled trials

Adem Y. Dawed, Andrea Mari, Andrew Brown et al. · The Lancet Diabetes & Endocrinology · 2022 · 105 citations · Full text

Medicine, Endocrinology, Pharmacology +13

Discovery of drug–omics associations in type 2 diabetes with generative deep-learning models

Rosa Lundbye Allesøe, Agnete Troen Lundgaard, Ricardo Hernández Medina et al. · Nature Biotechnology · 2023 · 105 citations · Full text

Life Sciences, Bioinformatics, Pharmacology +15

Four groups of type 2 diabetes contribute to the etiological and clinical heterogeneity in newly diagnosed individuals: An IMI DIRECT study

Agata Wesolowska‐Andersen, Caroline Brorsson, Roberto Bizzotto et al. · Cell Reports Medicine · 2022 · 89 citations · Full text

Medicine, Endocrinology, Internal Medicine +11